|
US2647121A
(en)
|
1951-02-02 |
1953-07-28 |
Ruth P Jacoby |
Diamine-bis-acetamides
|
|
US2819718A
(en)
|
1953-07-16 |
1958-01-14 |
Isidore H Goldman |
Drainage tube
|
|
US2717909A
(en)
|
1953-09-24 |
1955-09-13 |
Monsanto Chemicals |
Hydroxyethyl-keryl-alkylene-ammonium compounds
|
|
US2844629A
(en)
|
1956-04-25 |
1958-07-22 |
American Home Prod |
Fatty acid amides and derivatives thereof
|
|
US3096560A
(en)
|
1958-11-21 |
1963-07-09 |
William J Liebig |
Process for synthetic vascular implants
|
|
FR1378382A
(fr)
|
1962-12-01 |
1964-11-13 |
Sandoz Sa |
Amides de l'acide amino-propionique, utilisables en particulier pour le traitement des fibres textiles
|
|
GB1072118A
(en)
|
1962-12-01 |
1967-06-14 |
Sandoz Ag |
Amides of aminopropionic acid
|
|
JPS5141663B1
(ru)
|
1966-03-12 |
1976-11-11 |
|
|
|
JPS4822365B1
(ru)
|
1968-10-25 |
1973-07-05 |
|
|
|
NL143127B
(nl)
|
1969-02-04 |
1974-09-16 |
Rhone Poulenc Sa |
Versterkingsorgaan voor een defecte hartklep.
|
|
US3614955A
(en)
|
1970-02-09 |
1971-10-26 |
Medtronic Inc |
Standby defibrillator and method of operation
|
|
US3614954A
(en)
|
1970-02-09 |
1971-10-26 |
Medtronic Inc |
Electronic standby defibrillator
|
|
JPS5024216B1
(ru)
|
1970-12-29 |
1975-08-14 |
|
|
|
JPS5012146Y2
(ru)
|
1971-07-27 |
1975-04-15 |
|
|
|
US3945052A
(en)
|
1972-05-01 |
1976-03-23 |
Meadox Medicals, Inc. |
Synthetic vascular graft and method for manufacturing the same
|
|
US3805301A
(en)
|
1972-07-28 |
1974-04-23 |
Meadox Medicals Inc |
Tubular grafts having indicia thereon
|
|
JPS49127908A
(ru)
|
1973-04-20 |
1974-12-07 |
|
|
|
JPS5624664B2
(ru)
|
1973-06-28 |
1981-06-08 |
|
|
|
US4013507A
(en)
|
1973-09-18 |
1977-03-22 |
California Institute Of Technology |
Ionene polymers for selectively inhibiting the vitro growth of malignant cells
|
|
JPS5123537A
(ja)
|
1974-04-26 |
1976-02-25 |
Adeka Argus Chemical Co Ltd |
Kasozaisoseibutsu
|
|
GB1527592A
(en)
|
1974-08-05 |
1978-10-04 |
Ici Ltd |
Wound dressing
|
|
US3995623A
(en)
|
1974-12-23 |
1976-12-07 |
American Hospital Supply Corporation |
Multipurpose flow-directed catheter
|
|
JPS5813576B2
(ja)
|
1974-12-27 |
1983-03-14 |
アデカ ア−ガスカガク カブシキガイシヤ |
安定化された合成高分子組成物
|
|
DE2520814A1
(de)
|
1975-05-09 |
1976-11-18 |
Bayer Ag |
Lichtstabilisierung von polyurethanen
|
|
US4281669A
(en)
|
1975-05-09 |
1981-08-04 |
Macgregor David C |
Pacemaker electrode with porous system
|
|
JPS5210847A
(en)
|
1975-07-16 |
1977-01-27 |
Nippon Steel Corp |
Pinch roll
|
|
US4096860A
(en)
|
1975-10-08 |
1978-06-27 |
Mclaughlin William F |
Dual flow encatheter
|
|
CA1069652A
(en)
|
1976-01-09 |
1980-01-15 |
Alain F. Carpentier |
Supported bioprosthetic heart valve with compliant orifice ring
|
|
US4134402A
(en)
|
1976-02-11 |
1979-01-16 |
Mahurkar Sakharam D |
Double lumen hemodialysis catheter
|
|
US4072146A
(en)
|
1976-09-08 |
1978-02-07 |
Howes Randolph M |
Venous catheter device
|
|
US4335723A
(en)
|
1976-11-26 |
1982-06-22 |
The Kendall Company |
Catheter having inflatable retention means
|
|
US4099528A
(en)
|
1977-02-17 |
1978-07-11 |
Sorenson Research Co., Inc. |
Double lumen cannula
|
|
US4140126A
(en)
|
1977-02-18 |
1979-02-20 |
Choudhury M Hasan |
Method for performing aneurysm repair
|
|
US4265745A
(en)
|
1977-05-25 |
1981-05-05 |
Teijin Limited |
Permselective membrane
|
|
US4182833A
(en)
|
1977-12-07 |
1980-01-08 |
Celanese Polymer Specialties Company |
Cationic epoxide-amine reaction products
|
|
US4180068A
(en)
|
1978-04-13 |
1979-12-25 |
Motion Control, Incorporated |
Bi-directional flow catheter with retractable trocar/valve structure
|
|
DE2960875D1
(en)
|
1978-04-19 |
1981-12-10 |
Ici Plc |
A method of preparing a tubular product by electrostatic spinning
|
|
US4284459A
(en)
|
1978-07-03 |
1981-08-18 |
The Kendall Company |
Method for making a molded catheter
|
|
US4227533A
(en)
|
1978-11-03 |
1980-10-14 |
Bristol-Myers Company |
Flushable urinary catheter
|
|
US4375817A
(en)
|
1979-07-19 |
1983-03-08 |
Medtronic, Inc. |
Implantable cardioverter
|
|
US4500707A
(en)
|
1980-02-29 |
1985-02-19 |
University Patents, Inc. |
Nucleosides useful in the preparation of polynucleotides
|
|
US5132418A
(en)
|
1980-02-29 |
1992-07-21 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
US4458066A
(en)
|
1980-02-29 |
1984-07-03 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
DE3010841A1
(de)
|
1980-03-21 |
1981-10-08 |
Ulrich Dr.med. 6936 Haag Uthmann |
Katheder
|
|
US4308085A
(en)
|
1980-07-28 |
1981-12-29 |
Jenoptik Jena Gmbh |
Process for the preparation of high molecular thermoplastic epoxide-amine-polyadducts
|
|
US4973679A
(en)
|
1981-03-27 |
1990-11-27 |
University Patents, Inc. |
Process for oligonucleo tide synthesis using phosphormidite intermediates
|
|
US4668777A
(en)
|
1981-03-27 |
1987-05-26 |
University Patents, Inc. |
Phosphoramidite nucleoside compounds
|
|
US4415732A
(en)
|
1981-03-27 |
1983-11-15 |
University Patents, Inc. |
Phosphoramidite compounds and processes
|
|
US4339369A
(en)
|
1981-04-23 |
1982-07-13 |
Celanese Corporation |
Cationic epoxide-amine reaction products
|
|
US4401796A
(en)
|
1981-04-30 |
1983-08-30 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
|
US4373071A
(en)
|
1981-04-30 |
1983-02-08 |
City Of Hope Research Institute |
Solid-phase synthesis of polynucleotides
|
|
US4406656A
(en)
|
1981-06-01 |
1983-09-27 |
Brack Gillium Hattler |
Venous catheter having collapsible multi-lumens
|
|
US4475972A
(en)
|
1981-10-01 |
1984-10-09 |
Ontario Research Foundation |
Implantable material
|
|
US4401472A
(en)
|
1982-02-26 |
1983-08-30 |
Martin Marietta Corporation |
Hydraulic cement mixes and processes for improving hydraulic cement mixes
|
|
US4568329A
(en)
|
1982-03-08 |
1986-02-04 |
Mahurkar Sakharam D |
Double lumen catheter
|
|
US4546499A
(en)
|
1982-12-13 |
1985-10-15 |
Possis Medical, Inc. |
Method of supplying blood to blood receiving vessels
|
|
US4530113A
(en)
|
1983-05-20 |
1985-07-23 |
Intervascular, Inc. |
Vascular grafts with cross-weave patterns
|
|
US4550447A
(en)
|
1983-08-03 |
1985-11-05 |
Shiley Incorporated |
Vascular graft prosthesis
|
|
US4647416A
(en)
|
1983-08-03 |
1987-03-03 |
Shiley Incorporated |
Method of preparing a vascular graft prosthesis
|
|
US5104399A
(en)
|
1986-12-10 |
1992-04-14 |
Endovascular Technologies, Inc. |
Artificial graft and implantation method
|
|
US4710169A
(en)
|
1983-12-16 |
1987-12-01 |
Christopher T Graham |
Urinary catheter with collapsible urethral tube
|
|
US4571241A
(en)
|
1983-12-16 |
1986-02-18 |
Christopher T Graham |
Urinary catheter with collapsible urethral tube
|
|
US4737518A
(en)
|
1984-04-03 |
1988-04-12 |
Takeda Chemical Industries, Ltd. |
Lipid derivatives, their production and use
|
|
US4562596A
(en)
|
1984-04-25 |
1986-01-07 |
Elliot Kornberg |
Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
|
|
US4782836A
(en)
|
1984-05-24 |
1988-11-08 |
Intermedics, Inc. |
Rate adaptive cardiac pacemaker responsive to patient activity and temperature
|
|
US4897355A
(en)
|
1985-01-07 |
1990-01-30 |
Syntex (U.S.A.) Inc. |
N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
|
|
US4662382A
(en)
|
1985-01-16 |
1987-05-05 |
Intermedics, Inc. |
Pacemaker lead with enhanced sensitivity
|
|
US4762915A
(en)
|
1985-01-18 |
1988-08-09 |
Liposome Technology, Inc. |
Protein-liposome conjugates
|
|
US4860751A
(en)
|
1985-02-04 |
1989-08-29 |
Cordis Corporation |
Activity sensor for pacemaker control
|
|
US5223263A
(en)
|
1988-07-07 |
1993-06-29 |
Vical, Inc. |
Liponucleotide-containing liposomes
|
|
CA1320724C
(en)
|
1985-07-19 |
1993-07-27 |
Koichi Kanehira |
Terpene amino alcohols and medicinal uses thereof
|
|
US4701162A
(en)
|
1985-09-24 |
1987-10-20 |
The Kendall Company |
Foley catheter assembly
|
|
US4737323A
(en)
|
1986-02-13 |
1988-04-12 |
Liposome Technology, Inc. |
Liposome extrusion method
|
|
US5153319A
(en)
|
1986-03-31 |
1992-10-06 |
University Patents, Inc. |
Process for preparing polynucleotides
|
|
DE3616824A1
(de)
|
1986-05-17 |
1987-11-19 |
Schering Ag |
Verwendung von haertbaren kunstharzmischungen fuer oberflaechenbeschichtungen und druckfarben und verfahren zu ihrer herstellung
|
|
EP0255899B1
(de)
|
1986-07-31 |
1992-07-15 |
Werner Prof. Dr.-Ing. Irnich |
Frequenzadaptierender Herzschrittmacher
|
|
US4960409A
(en)
|
1986-09-11 |
1990-10-02 |
Catalano Marc L |
Method of using bilumen peripheral venous catheter with adapter
|
|
JPH0829776B2
(ja)
|
1986-10-29 |
1996-03-27 |
東燃化学株式会社 |
合成樹脂製容器及びその製造用金型
|
|
US4720517A
(en)
|
1986-11-24 |
1988-01-19 |
Ciba-Geigy Corporation |
Compositions stabilized with N-hydroxyiminodiacetic and dipropionic acids and esters thereof
|
|
US4920016A
(en)
|
1986-12-24 |
1990-04-24 |
Linear Technology, Inc. |
Liposomes with enhanced circulation time
|
|
DE3728917A1
(de)
|
1987-08-29 |
1989-03-09 |
Roth Hermann J |
Neue lipide mit unsymmetrisch substituierter disulfidbruecke
|
|
US4946683A
(en)
|
1987-11-18 |
1990-08-07 |
Vestar, Inc. |
Multiple step entrapment/loading procedure for preparing lipophilic drug-containing liposomes
|
|
US4843155A
(en)
|
1987-11-19 |
1989-06-27 |
Piotr Chomczynski |
Product and process for isolating RNA
|
|
US5138067A
(en)
|
1987-12-17 |
1992-08-11 |
Shionogi & Co. Ltd. |
Lipid derivatives
|
|
US5047540A
(en)
|
1987-12-17 |
1991-09-10 |
Shionogi & Co., Ltd. |
Lipid derivatives
|
|
US4892540A
(en)
|
1988-04-21 |
1990-01-09 |
Sorin Biomedica S.P.A. |
Two-leaflet prosthetic heart valve
|
|
US5176661A
(en)
|
1988-09-06 |
1993-01-05 |
Advanced Cardiovascular Systems, Inc. |
Composite vascular catheter
|
|
US5024671A
(en)
|
1988-09-19 |
1991-06-18 |
Baxter International Inc. |
Microporous vascular graft
|
|
US5200395A
(en)
|
1988-10-18 |
1993-04-06 |
Ajinomoto Company, Inc. |
Pharmaceutical composition of BUF-5 for treating anemia
|
|
CA2001401A1
(en)
|
1988-10-25 |
1990-04-25 |
Claude Piantadosi |
Quaternary amine containing ether or ester lipid derivatives and therapeutic compositions
|
|
US5262530A
(en)
|
1988-12-21 |
1993-11-16 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
US5047524A
(en)
|
1988-12-21 |
1991-09-10 |
Applied Biosystems, Inc. |
Automated system for polynucleotide synthesis and purification
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
|
NL8900725A
(nl)
*
|
1989-03-23 |
1990-10-16 |
Az Univ Amsterdam |
Werkwijze en combinatie van middelen voor het isoleren van nucleinezuur.
|
|
FR2645866B1
(fr)
|
1989-04-17 |
1991-07-05 |
Centre Nat Rech Scient |
Nouvelles lipopolyamines, leur preparation et leur emploi
|
|
US5194654A
(en)
|
1989-11-22 |
1993-03-16 |
Vical, Inc. |
Lipid derivatives of phosphonoacids for liposomal incorporation and method of use
|
|
US5863770A
(en)
*
|
1989-08-22 |
1999-01-26 |
Hsc Research And Development Limited Partnership |
Stable meterologous propagation of CFTR protein variant cDNA
|
|
US5279833A
(en)
|
1990-04-04 |
1994-01-18 |
Yale University |
Liposomal transfection of nucleic acids into animal cells
|
|
US5101824A
(en)
|
1990-04-16 |
1992-04-07 |
Siemens-Pacesetter, Inc. |
Rate-responsive pacemaker with circuitry for processing multiple sensor inputs
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
US5405379A
(en)
|
1990-07-26 |
1995-04-11 |
Lane; Rodney J. |
Self expanding vascular endoprosthesis for aneurysms
|
|
US5693338A
(en)
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
|
JPH0765267B2
(ja)
|
1990-08-22 |
1995-07-12 |
花王株式会社 |
柔軟仕上剤
|
|
US5256294A
(en)
|
1990-09-17 |
1993-10-26 |
Genentech, Inc. |
Tangential flow filtration process and apparatus
|
|
DE9117152U1
(de)
|
1990-10-09 |
1996-07-11 |
Cook Inc |
Stent
|
|
ATE120971T1
(de)
|
1990-12-19 |
1995-04-15 |
Osypka Peter |
Herzschrittmacherleitung mit einem inneren kanal und mit einem elektrodenkopf.
|
|
US5116360A
(en)
|
1990-12-27 |
1992-05-26 |
Corvita Corporation |
Mesh composite graft
|
|
JP2547524Y2
(ja)
|
1991-01-22 |
1997-09-10 |
東洋ラジエーター株式会社 |
オイルクーラ
|
|
US5405363A
(en)
|
1991-03-15 |
1995-04-11 |
Angelon Corporation |
Implantable cardioverter defibrillator having a smaller displacement volume
|
|
US5330768A
(en)
|
1991-07-05 |
1994-07-19 |
Massachusetts Institute Of Technology |
Controlled drug delivery using polymer/pluronic blends
|
|
US5545449A
(en)
|
1991-10-02 |
1996-08-13 |
Weyerhaeuser Company |
Polyether-reinforced fiber-based materials
|
|
US5151105A
(en)
|
1991-10-07 |
1992-09-29 |
Kwan Gett Clifford |
Collapsible vessel sleeve implant
|
|
US5284491A
(en)
|
1992-02-27 |
1994-02-08 |
Medtronic, Inc. |
Cardiac pacemaker with hysteresis behavior
|
|
US5352461A
(en)
|
1992-03-11 |
1994-10-04 |
Pharmaceutical Discovery Corporation |
Self assembling diketopiperazine drug delivery system
|
|
SE9200951D0
(sv)
|
1992-03-27 |
1992-03-27 |
Kabi Pharmacia Ab |
Pharmaceutical composition containing a defined lipid system
|
|
CA2132342A1
(en)
|
1992-04-06 |
1993-10-14 |
Kenneth F. Buechler |
Novel opiate derivatives and protein and polypeptide opiate derivative conjugates and labels
|
|
US6670178B1
(en)
|
1992-07-10 |
2003-12-30 |
Transkaryotic Therapies, Inc. |
In Vivo production and delivery of insulinotropin for gene therapy
|
|
KR950702628A
(ko)
|
1992-08-01 |
1995-07-29 |
치세이 라 |
항알레르기 조성물(Antiallergic agent)
|
|
US5334761A
(en)
|
1992-08-28 |
1994-08-02 |
Life Technologies, Inc. |
Cationic lipids
|
|
US5461223A
(en)
|
1992-10-09 |
1995-10-24 |
Eastman Kodak Company |
Bar code detecting circuitry
|
|
US5300022A
(en)
|
1992-11-12 |
1994-04-05 |
Martin Klapper |
Urinary catheter and bladder irrigation system
|
|
US5496362A
(en)
|
1992-11-24 |
1996-03-05 |
Cardiac Pacemakers, Inc. |
Implantable conformal coil patch electrode with multiple conductive elements for cardioversion and defibrillation
|
|
US5552155A
(en)
|
1992-12-04 |
1996-09-03 |
The Liposome Company, Inc. |
Fusogenic lipsomes and methods for making and using same
|
|
US5716395A
(en)
|
1992-12-11 |
1998-02-10 |
W.L. Gore & Associates, Inc. |
Prosthetic vascular graft
|
|
WO1994018987A1
(en)
|
1993-02-19 |
1994-09-01 |
Nippon Shinyaku Co., Ltd. |
Drug composition containing nucleic acid copolymer
|
|
US5395619A
(en)
|
1993-03-03 |
1995-03-07 |
Liposome Technology, Inc. |
Lipid-polymer conjugates and liposomes
|
|
US5697953A
(en)
|
1993-03-13 |
1997-12-16 |
Angeion Corporation |
Implantable cardioverter defibrillator having a smaller displacement volume
|
|
US5624976A
(en)
|
1994-03-25 |
1997-04-29 |
Dentsply Gmbh |
Dental filling composition and method
|
|
US5314430A
(en)
|
1993-06-24 |
1994-05-24 |
Medtronic, Inc. |
Atrial defibrillator employing transvenous and subcutaneous electrodes and method of use
|
|
DE4321904B4
(de)
|
1993-07-01 |
2013-05-16 |
Qiagen Gmbh |
Verfahren zur chromatographischen Reinigung und Trennung von Nucleinsäuregemischen
|
|
DE4325848A1
(de)
|
1993-07-31 |
1995-02-02 |
Basf Ag |
Verfahren zur Herstellung von N-(2-Hydroxyethyl)-piperazin
|
|
EP0875280B1
(en)
|
1993-10-06 |
2001-08-22 |
The Kansai Electric Power Co., Inc. |
Method for removing carbon dioxide from combustion exhaust gas
|
|
US5609624A
(en)
|
1993-10-08 |
1997-03-11 |
Impra, Inc. |
Reinforced vascular graft and method of making same
|
|
SE9303481L
(sv)
|
1993-10-22 |
1995-04-23 |
Berol Nobel Ab |
Hygienkomposition
|
|
AU1091095A
(en)
|
1993-11-08 |
1995-05-29 |
Harrison M. Lazarus |
Intraluminal vascular graft and method
|
|
JPH09505593A
(ja)
|
1993-11-24 |
1997-06-03 |
メガバイオス・コーポレイション |
ピペラジンの両親媒性誘導体
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US5464924A
(en)
|
1994-01-07 |
1995-11-07 |
The Dow Chemical Company |
Flexible poly(amino ethers) for barrier packaging
|
|
ATE302208T1
(de)
*
|
1994-02-11 |
2005-09-15 |
Qiagen Gmbh |
Verfahren zur trennung von doppelstrang/einzelstrangnukleinsäurestrukturen
|
|
US5844107A
(en)
|
1994-03-23 |
1998-12-01 |
Case Western Reserve University |
Compacted nucleic acids and their delivery to cells
|
|
WO1995027478A1
(en)
|
1994-04-12 |
1995-10-19 |
The Liposome Company, Inc. |
Fusogenic liposomes and methods of making and using same
|
|
US5776747A
(en)
|
1994-07-20 |
1998-07-07 |
Cytotherapeutics, Inc. |
Method for controlling the distribution of cells within a bioartificial organ using polycthylene oxide-poly (dimethylsiloxane) copolymer
|
|
US5820873A
(en)
|
1994-09-30 |
1998-10-13 |
The University Of British Columbia |
Polyethylene glycol modified ceramide lipids and liposome uses thereof
|
|
US5885613A
(en)
|
1994-09-30 |
1999-03-23 |
The University Of British Columbia |
Bilayer stabilizing components and their use in forming programmable fusogenic liposomes
|
|
US5641665A
(en)
|
1994-11-28 |
1997-06-24 |
Vical Incorporated |
Plasmids suitable for IL-2 expression
|
|
US6071890A
(en)
|
1994-12-09 |
2000-06-06 |
Genzyme Corporation |
Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
|
|
US5965434A
(en)
|
1994-12-29 |
1999-10-12 |
Wolff; Jon A. |
Amphipathic PH sensitive compounds and delivery systems for delivering biologically active compounds
|
|
US6485726B1
(en)
|
1995-01-17 |
2002-11-26 |
The Brigham And Women's Hospital, Inc. |
Receptor specific transepithelial transport of therapeutics
|
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
|
EP0822835A1
(en)
|
1995-04-17 |
1998-02-11 |
Imarx Pharmaceutical Corp. |
Hybrid magnetic resonance contrast agents
|
|
US20010047091A1
(en)
*
|
1998-09-09 |
2001-11-29 |
Brian Miki |
Cryptic regulatory elements obtained from plants
|
|
US5772694A
(en)
|
1995-05-16 |
1998-06-30 |
Medical Carbon Research Institute L.L.C. |
Prosthetic heart valve with improved blood flow
|
|
US5700642A
(en)
|
1995-05-22 |
1997-12-23 |
Sri International |
Oligonucleotide sizing using immobilized cleavable primers
|
|
US5783383A
(en)
|
1995-05-23 |
1998-07-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method of detecting cytomegalovirus (CMV)
|
|
US5705385A
(en)
|
1995-06-07 |
1998-01-06 |
Inex Pharmaceuticals Corporation |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
|
US5609629A
(en)
|
1995-06-07 |
1997-03-11 |
Med Institute, Inc. |
Coated implantable medical device
|
|
US7422902B1
(en)
|
1995-06-07 |
2008-09-09 |
The University Of British Columbia |
Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
|
|
JP4335310B2
(ja)
|
1995-06-07 |
2009-09-30 |
ザ ユニバーシティ オブ ブリティッシュ コロンビア |
疎水性脂質−核酸複合中間体を通して調製される脂質−核酸粒子、及び遺伝子移送のための使用
|
|
US5981501A
(en)
|
1995-06-07 |
1999-11-09 |
Inex Pharmaceuticals Corp. |
Methods for encapsulating plasmids in lipid bilayers
|
|
US5607385A
(en)
|
1995-08-17 |
1997-03-04 |
Medtronic, Inc. |
Device and algorithm for a combined cardiomyostimulator and a cardiac pacer-carioverter-defibrillator
|
|
US5744335A
(en)
|
1995-09-19 |
1998-04-28 |
Mirus Corporation |
Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein
|
|
FR2740978B1
(fr)
|
1995-11-10 |
1998-01-02 |
Ela Medical Sa |
Dispositif medical actif du type defibrillateur/cardioverteur implantable
|
|
US5874105A
(en)
|
1996-01-31 |
1999-02-23 |
Collaborative Laboratories, Inc. |
Lipid vesicles formed with alkylammonium fatty acid salts
|
|
US6417326B1
(en)
|
1996-04-11 |
2002-07-09 |
The University Of British Columbia |
Fusogenic liposomes
|
|
US5935936A
(en)
|
1996-06-03 |
1999-08-10 |
Genzyme Corporation |
Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
|
|
US5913848A
(en)
|
1996-06-06 |
1999-06-22 |
Luther Medical Products, Inc. |
Hard tip over-the-needle catheter and method of manufacturing the same
|
|
US5677124A
(en)
|
1996-07-03 |
1997-10-14 |
Ambion, Inc. |
Ribonuclease resistant viral RNA standards
|
|
JP3734189B2
(ja)
|
1996-07-19 |
2006-01-11 |
株式会社小松製作所 |
２ピースブーム型建設機械のストロークエンドショック低減装置
|
|
EP0921780A1
(en)
|
1996-07-23 |
1999-06-16 |
Raymond L. Mitchell |
Wheelchair propulsion kit
|
|
US5736573A
(en)
|
1996-07-31 |
1998-04-07 |
Galat; Alexander |
Lipid and water soluble derivatives of drugs
|
|
US6011148A
(en)
*
|
1996-08-01 |
2000-01-04 |
Megabios Corporation |
Methods for purifying nucleic acids
|
|
US7288266B2
(en)
|
1996-08-19 |
2007-10-30 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
|
CA2264140A1
(en)
|
1996-08-26 |
1998-03-05 |
Transgene S.A. |
Cationic lipid-nucleic acid complexes
|
|
ES2305157T3
(es)
|
1996-09-13 |
2008-11-01 |
Lipoxen Technologies Limited |
Liposomas.
|
|
TW520297B
(en)
|
1996-10-11 |
2003-02-11 |
Sequus Pharm Inc |
Fusogenic liposome composition and method
|
|
WO1998019709A2
(en)
|
1996-11-04 |
1998-05-14 |
Qiagen Gmbh |
Cationic reagents for transfection
|
|
US6887665B2
(en)
|
1996-11-14 |
2005-05-03 |
Affymetrix, Inc. |
Methods of array synthesis
|
|
CN1244215B
(zh)
|
1996-11-20 |
2010-11-03 |
荷兰克鲁塞尔公司 |
改进的腺病毒载体生产和纯化方法
|
|
US5985930A
(en)
*
|
1996-11-21 |
1999-11-16 |
Pasinetti; Giulio M. |
Treatment of neurodegenerative conditions with nimesulide
|
|
US6204297B1
(en)
|
1996-11-26 |
2001-03-20 |
Rhodia Inc. |
Nonionic gemini surfactants
|
|
JPH10197978A
(ja)
|
1997-01-09 |
1998-07-31 |
Mitsubishi Paper Mills Ltd |
ハロゲン化銀写真感光材料
|
|
EP0853123A1
(de)
|
1997-01-10 |
1998-07-15 |
Roche Diagnostics GmbH |
Reinigung von DNA durch Cross-Flow-Filtration
|
|
FR2760193B1
(fr)
|
1997-02-28 |
1999-05-28 |
Transgene Sa |
Lipides et complexes de lipides cationiques et de substances actives, notamment pour la transfection de cellules
|
|
US5837283A
(en)
|
1997-03-12 |
1998-11-17 |
The Regents Of The University Of California |
Cationic lipid compositions targeting angiogenic endothelial cells
|
|
US5945326A
(en)
|
1997-03-20 |
1999-08-31 |
New England Biolabs, Inc. |
Method for cloning and producing the Spel restriction endonuclease
|
|
US6835395B1
(en)
|
1997-05-14 |
2004-12-28 |
The University Of British Columbia |
Composition containing small multilamellar oligodeoxynucleotide-containing lipid vesicles
|
|
DE69841002D1
(de)
|
1997-05-14 |
2009-09-03 |
Univ British Columbia |
Hochwirksame verkapselung von nukleinsäuren in lipidvesikeln
|
|
US20030104044A1
(en)
|
1997-05-14 |
2003-06-05 |
Semple Sean C. |
Compositions for stimulating cytokine secretion and inducing an immune response
|
|
JPH115786A
(ja)
|
1997-06-13 |
1999-01-12 |
Pola Chem Ind Inc |
新規アミノヒドロキシプロピルピペラジン誘導体
|
|
WO1998059076A1
(en)
|
1997-06-25 |
1998-12-30 |
Promega Corporation |
Method of isolating rna
|
|
EP1007683A1
(en)
*
|
1997-07-12 |
2000-06-14 |
Societe Des Produits Nestle S.A. |
Coffee storage proteins
|
|
US6067471A
(en)
|
1998-08-07 |
2000-05-23 |
Cardiac Pacemakers, Inc. |
Atrial and ventricular implantable cardioverter-defibrillator and lead system
|
|
JPH1180142A
(ja)
|
1997-09-05 |
1999-03-26 |
Pola Chem Ind Inc |
ジフェニルアルキル化合物の製造法
|
|
AU9319398A
(en)
|
1997-09-19 |
1999-04-05 |
Sequitur, Inc. |
Sense mrna therapy
|
|
DE19746874A1
(de)
|
1997-10-23 |
1999-04-29 |
Qiagen Gmbh |
Verfahren zur Isolierung und Reinigung von Nukleinsäuren an hydrophoben Oberflächen - insbesondere unter Verwendung hydrophober Membranen
|
|
US6165763A
(en)
|
1997-10-30 |
2000-12-26 |
Smithkline Beecham Corporation |
Ornithine carbamoyltransferase
|
|
US5972613A
(en)
|
1997-12-09 |
1999-10-26 |
The Perkin-Elmer Corporation |
Methods of nucleic acid isolation
|
|
US6096075A
(en)
|
1998-01-22 |
2000-08-01 |
Medical Carbon Research Institute, Llc |
Prosthetic heart valve
|
|
US6617171B2
(en)
|
1998-02-27 |
2003-09-09 |
The General Hospital Corporation |
Methods for diagnosing and treating autoimmune disease
|
|
US20020115135A1
(en)
*
|
1998-03-06 |
2002-08-22 |
Henry Yue |
Synapse related glycoproteins
|
|
US6271209B1
(en)
|
1998-04-03 |
2001-08-07 |
Valentis, Inc. |
Cationic lipid formulation delivering nucleic acid to peritoneal tumors
|
|
US6176877B1
(en)
|
1998-04-20 |
2001-01-23 |
St. Jude Medical, Inc. |
Two piece prosthetic heart valve
|
|
US6986902B1
(en)
|
1998-04-28 |
2006-01-17 |
Inex Pharmaceuticals Corporation |
Polyanionic polymers which enhance fusogenicity
|
|
DE19822602A1
(de)
|
1998-05-20 |
1999-11-25 |
Goldschmidt Ag Th |
Verfahren zur Herstellung von Polyaminosäureestern durch Veresterung von sauren Polyaminosäuren oder Umesterung von Polyaminosäureestern
|
|
NO313244B1
(no)
|
1998-07-08 |
2002-09-02 |
Crew Dev Corp |
Fremgangsmåte for isolering og produksjon av magnesitt eller magnesiumklorid
|
|
US6055454A
(en)
|
1998-07-27 |
2000-04-25 |
Cardiac Pacemakers, Inc. |
Cardiac pacemaker with automatic response optimization of a physiologic sensor based on a second sensor
|
|
US6299604B1
(en)
|
1998-08-20 |
2001-10-09 |
Cook Incorporated |
Coated implantable medical device
|
|
US6210892B1
(en)
|
1998-10-07 |
2001-04-03 |
Isis Pharmaceuticals, Inc. |
Alteration of cellular behavior by antisense modulation of mRNA processing
|
|
US20030064951A1
(en)
*
|
1998-11-12 |
2003-04-03 |
Valentis, Inc. |
Methods for purifying nucleic acids
|
|
WO2000030444A1
(en)
|
1998-11-25 |
2000-06-02 |
Vanderbilt University |
Cationic liposomes for gene transfer
|
|
US6248725B1
(en)
|
1999-02-23 |
2001-06-19 |
Amgen, Inc. |
Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
|
|
US6379698B1
(en)
|
1999-04-06 |
2002-04-30 |
Isis Pharmaceuticals, Inc. |
Fusogenic lipids and vesicles
|
|
WO2000062813A2
(en)
|
1999-04-20 |
2000-10-26 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
|
CN1244376C
(zh)
|
1999-04-23 |
2006-03-08 |
阿尔萨公司 |
可释放的键和含有该键的组合物
|
|
US6169923B1
(en)
|
1999-04-23 |
2001-01-02 |
Pacesetter, Inc. |
Implantable cardioverter-defibrillator with automatic arrhythmia detection criteria adjustment
|
|
US6794140B1
(en)
|
1999-04-30 |
2004-09-21 |
Andrew Simon Goldsborough |
Isolation of nucleic acid
|
|
ATE369384T1
(de)
|
1999-05-19 |
2007-08-15 |
Emd Lexigen Res Ct Corp |
Expression und export von interferon-alpha proteinen als fc fusionsproteine
|
|
US6696424B1
(en)
|
1999-05-28 |
2004-02-24 |
Vical Incorporated |
Cytofectin dimers and methods of use thereof
|
|
US6346382B1
(en)
|
1999-06-01 |
2002-02-12 |
Vanderbilt University |
Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto
|
|
US20020010145A1
(en)
|
1999-07-12 |
2002-01-24 |
Willson Richard C. |
Apparatus, methods and compositions for biotechnical separations
|
|
EP1202714A1
(en)
|
1999-07-16 |
2002-05-08 |
Purdue Research Foundation |
Vinyl ether lipids with cleavable hydrophilic headgroups
|
|
US6313285B1
(en)
|
1999-07-23 |
2001-11-06 |
Genentech, Inc. |
Purification of plasmid DNA
|
|
US6358278B1
(en)
|
1999-09-24 |
2002-03-19 |
St. Jude Medical, Inc. |
Heart valve prosthesis with rotatable cuff
|
|
US6371983B1
(en)
|
1999-10-04 |
2002-04-16 |
Ernest Lane |
Bioprosthetic heart valve
|
|
US7060291B1
(en)
|
1999-11-24 |
2006-06-13 |
Transave, Inc. |
Modular targeted liposomal delivery system
|
|
CN1433478A
(zh)
|
1999-12-30 |
2003-07-30 |
诺瓦提斯公司 |
用于基因治疗的新的胶体合成载体
|
|
JP3460673B2
(ja)
*
|
2000-02-04 |
2003-10-27 |
浜松ホトニクス株式会社 |
特定の遺伝子を発現した生細胞の選択的分離方法
|
|
EP1261379A2
(en)
|
2000-02-17 |
2002-12-04 |
Genzyme Corporation |
Genetic modification of the lung as a portal for gene delivery
|
|
US6370434B1
(en)
|
2000-02-28 |
2002-04-09 |
Cardiac Pacemakers, Inc. |
Cardiac lead and method for lead implantation
|
|
US6565960B2
(en)
|
2000-06-01 |
2003-05-20 |
Shriners Hospital Of Children |
Polymer composite compositions
|
|
IL138474A0
(en)
|
2000-09-14 |
2001-10-31 |
Epox Ltd |
Highly branched water-soluble polyamine oligomers, process for their preparation and applications thereof
|
|
USRE43612E1
(en)
|
2000-10-10 |
2012-08-28 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
|
US7427394B2
(en)
|
2000-10-10 |
2008-09-23 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
|
US6998115B2
(en)
|
2000-10-10 |
2006-02-14 |
Massachusetts Institute Of Technology |
Biodegradable poly(β-amino esters) and uses thereof
|
|
CA2426244A1
(en)
|
2000-10-25 |
2002-05-02 |
The University Of British Columbia |
Lipid formulations for target delivery
|
|
GB0028361D0
(en)
|
2000-11-21 |
2001-01-03 |
Glaxo Group Ltd |
Method of separating extra chromosomal dna from other cellular components
|
|
US20020094528A1
(en)
|
2000-11-29 |
2002-07-18 |
Salafsky Joshua S. |
Method and apparatus using a surface-selective nonlinear optical technique for detection of probe-target interations
|
|
JP2002167368A
(ja)
|
2000-12-01 |
2002-06-11 |
Nitto Denko Corp |
アルキル置換デンドリマーおよびその製造法
|
|
US20050004058A1
(en)
|
2000-12-07 |
2005-01-06 |
Patrick Benoit |
Sequences upstream of the carp gene, vectors containing them and uses thereof
|
|
JP2004527236A
(ja)
*
|
2001-02-14 |
2004-09-09 |
ベイラー カレッジ オブ メディスン |
Ｒｎａ増幅の方法及び組成物
|
|
DE10109897A1
(de)
|
2001-02-21 |
2002-11-07 |
Novosom Ag |
Fakultativ kationische Liposomen und Verwendung dieser
|
|
US20020192721A1
(en)
|
2001-03-28 |
2002-12-19 |
Engeneos, Inc. |
Modular molecular clasps and uses thereof
|
|
KR100823815B1
(ko)
|
2001-04-23 |
2008-04-21 |
신에쓰 가가꾸 고교 가부시끼가이샤 |
에스테르 구조를 갖는 신규 3급 아민 화합물 및 그 제조방법
|
|
US6585410B1
(en)
|
2001-05-03 |
2003-07-01 |
The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration |
Radiant temperature nulling radiometer
|
|
ES2340532T3
(es)
|
2001-06-05 |
2010-06-04 |
Curevac Gmbh |
Arnm con un contenido g/c aumentado que codifica para un antigeno bacteriano y utilizacion del mismo.
|
|
US7124372B2
(en)
|
2001-06-13 |
2006-10-17 |
Glen David Brin |
Interactive communication between a plurality of users
|
|
US20030044771A1
(en)
*
|
2001-08-30 |
2003-03-06 |
Anderson Norman G. |
Method for discovering new infectious particles
|
|
EP2428571B1
(en)
|
2001-09-28 |
2018-07-18 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
MicroRNA molecules
|
|
CA2463317A1
(en)
|
2001-10-12 |
2003-04-24 |
Gentra Systems, Inc. |
Compositions and methods for using a solid support to purify rna
|
|
CA2466328A1
(en)
|
2001-11-09 |
2003-05-15 |
Bayer Healthcare Ag |
Isotopically coded affinity markers 3
|
|
DE10162480A1
(de)
|
2001-12-19 |
2003-08-07 |
Ingmar Hoerr |
Die Applikation von mRNA für den Einsatz als Therapeutikum gegen Tumorerkrankungen
|
|
DE10207178A1
(de)
|
2002-02-19 |
2003-09-04 |
Novosom Ag |
Komponenten für die Herstellung amphoterer Liposomen
|
|
US20030170637A1
(en)
*
|
2002-03-06 |
2003-09-11 |
Pirrung Michael C. |
Method of analyzing mRNA splice variants
|
|
AU2003220249A1
(en)
|
2002-03-15 |
2003-09-29 |
Arcturus Bioscience, Inc. |
Improved nucleic acid amplification
|
|
DE10214983A1
(de)
|
2002-04-04 |
2004-04-08 |
TransMIT Gesellschaft für Technologietransfer mbH |
Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
|
|
GB0208390D0
(en)
*
|
2002-04-11 |
2002-05-22 |
Univ London |
Adeno-associated virus producer system
|
|
US20060217535A1
(en)
*
|
2002-05-09 |
2006-09-28 |
Debra Yuhas |
Hemipteran muscarinic receptor
|
|
US20030215395A1
(en)
|
2002-05-14 |
2003-11-20 |
Lei Yu |
Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
|
|
US7601367B2
(en)
|
2002-05-28 |
2009-10-13 |
Mirus Bio Llc |
Compositions and processes using siRNA, amphipathic compounds and polycations
|
|
DE60230071D1
(de)
*
|
2002-06-14 |
2009-01-08 |
Monier Tadros |
Methode für die herstellung von protamin
|
|
WO2004002453A1
(en)
|
2002-06-28 |
2004-01-08 |
Protiva Biotherapeutics Ltd. |
Method and apparatus for producing liposomes
|
|
DE10229872A1
(de)
|
2002-07-03 |
2004-01-29 |
Curevac Gmbh |
Immunstimulation durch chemisch modifizierte RNA
|
|
US20040028804A1
(en)
|
2002-08-07 |
2004-02-12 |
Anderson Daniel G. |
Production of polymeric microarrays
|
|
EP1539936A2
(en)
|
2002-08-22 |
2005-06-15 |
Celltran Limited |
Cell culture surface
|
|
US20060160759A1
(en)
*
|
2002-09-28 |
2006-07-20 |
Jianzhu Chen |
Influenza therapeutic
|
|
JP2006505644A
(ja)
|
2002-11-04 |
2006-02-16 |
ジーイー・バイエル・シリコーンズ・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング・ウント・コンパニー・コマンジツトゲゼルシヤフト |
線状ポリアミノおよび／またはポリアンモニウムポリシロキサン共重合体ｉ
|
|
JP2006515574A
(ja)
|
2002-11-22 |
2006-06-01 |
ノボ・ノルデイスク・エー／エス |
肥満症の治療に使用される化合物
|
|
US7169892B2
(en)
|
2003-01-10 |
2007-01-30 |
Astellas Pharma Inc. |
Lipid-peptide-polymer conjugates for long blood circulation and tumor specific drug delivery systems
|
|
KR100774067B1
(ko)
|
2003-01-20 |
2007-11-06 |
아사히 가세이 일렉트로닉스 가부시끼가이샤 |
포인팅 디바이스
|
|
AU2004217437B2
(en)
|
2003-03-05 |
2009-11-19 |
Senesco Technologies, Inc. |
Use of antisense oligonucleotides or siRNA to suppress expression of eIF-5A1
|
|
US7267950B2
(en)
|
2003-05-01 |
2007-09-11 |
Veridex, Lcc |
Rapid extraction of RNA from cells and tissues
|
|
US20040224912A1
(en)
|
2003-05-07 |
2004-11-11 |
Isis Pharmaceuticals Inc. |
Modulation of PAI-1 mRNA-binding protein expression
|
|
US7619017B2
(en)
|
2003-05-19 |
2009-11-17 |
Wacker Chemical Corporation |
Polymer emulsions resistant to biodeterioration
|
|
WO2005007810A2
(en)
|
2003-06-16 |
2005-01-27 |
Grinstaff Mark W |
Functional synthetic molecules and macromolecules for gene delivery
|
|
US20050059024A1
(en)
*
|
2003-07-25 |
2005-03-17 |
Ambion, Inc. |
Methods and compositions for isolating small RNA molecules
|
|
US20050042660A1
(en)
*
|
2003-07-31 |
2005-02-24 |
Hall Gerald Edward |
Devices and methods for isolating RNA
|
|
NZ592917A
(en)
|
2003-09-15 |
2012-12-21 |
Protiva Biotherapeutics Inc |
Stable polyethyleneglycol (PEG) dialkyloxypropyl (DAA) lipid conjugates
|
|
WO2005028619A2
(en)
|
2003-09-15 |
2005-03-31 |
Massachusetts Institute Of Technology |
Nanoliter-scale synthesis of arrayed biomaterials and screening thereof
|
|
US20050069590A1
(en)
|
2003-09-30 |
2005-03-31 |
Buehler Gail K. |
Stable suspensions for medicinal dosages
|
|
AU2004279991B2
(en)
|
2003-10-10 |
2010-11-25 |
Powderject Vaccines, Inc. |
Nucleic acid constructs
|
|
WO2005037226A2
(en)
|
2003-10-17 |
2005-04-28 |
Georgia Tech Research Corporation |
Genetically engineered enteroendocrine cells for treating glucose-related metabolic disorders
|
|
EP1683784A4
(en)
|
2003-11-10 |
2007-08-22 |
Nippon Kayaku Kk |
DIIMONIUM SALT CONNECTION AND ITS USE
|
|
US7318898B2
(en)
*
|
2003-11-18 |
2008-01-15 |
Exxonmobil Research And Engineering Company |
Polymeric membrane wafer assembly and method
|
|
US8075780B2
(en)
|
2003-11-24 |
2011-12-13 |
Millipore Corporation |
Purification and concentration of synthetic biological molecules
|
|
ATE466080T1
(de)
|
2003-12-16 |
2010-05-15 |
Qiagen North American Holdings |
Formulierungen und verfahren zum denaturieren von proteinen
|
|
US7022214B2
(en)
|
2004-01-21 |
2006-04-04 |
Bio-Rad Laboratories, Inc. |
Carrier ampholytes of high pH range
|
|
ITMI20040167A1
(it)
|
2004-02-04 |
2004-05-04 |
Univ Padova |
Metodo per l'estrazione simultanea di acidi nucleici da un campione biologico
|
|
US7556684B2
(en)
|
2004-02-26 |
2009-07-07 |
Construction Research & Technology Gmbh |
Amine containing strength improvement admixture
|
|
US20060228404A1
(en)
|
2004-03-04 |
2006-10-12 |
Anderson Daniel G |
Compositions and methods for treatment of hypertrophic tissues
|
|
WO2005093052A1
(en)
|
2004-03-26 |
2005-10-06 |
Fuji Photo Film Co., Ltd. |
Method for selectively separating and purifying rna and method for separating and purifying nucleic acid
|
|
US7794932B2
(en)
|
2004-04-16 |
2010-09-14 |
Piotr Chomczynski |
Reagents and methods for isolation of purified RNA
|
|
EP1781593B1
(en)
|
2004-06-07 |
2011-12-14 |
Protiva Biotherapeutics Inc. |
Cationic lipids and methods of use
|
|
ATE536418T1
(de)
|
2004-06-07 |
2011-12-15 |
Protiva Biotherapeutics Inc |
Lipidverkapselte interferenz-rna
|
|
US7670595B2
(en)
|
2004-06-28 |
2010-03-02 |
Merck Patent Gmbh |
Fc-interferon-beta fusion proteins
|
|
US20060099605A1
(en)
|
2004-11-11 |
2006-05-11 |
Hall Gerald E Jr |
Devices and methods for isolating RNA
|
|
GB0418172D0
(en)
|
2004-08-13 |
2004-09-15 |
Ic Vec Ltd |
Vector
|
|
US7361465B2
(en)
*
|
2004-09-07 |
2008-04-22 |
Applera Corporation |
Methods and compositions for tailing and amplifying RNA
|
|
DE102004043342A1
(de)
|
2004-09-08 |
2006-03-09 |
Bayer Materialscience Ag |
Blockierte Polyurethan-Prepolymere als Klebstoffe
|
|
AU2005300638A1
(en)
|
2004-11-05 |
2006-05-11 |
Novosom Ag |
Improvements in or relating to pharmaceutical compositions comprising an oligonucleotide as an active agent
|
|
EP1856262B1
(en)
|
2005-01-31 |
2012-08-15 |
Merck Sharp & Dohme Corp. |
Upstream and a downstream purification process for large scale production of plasmid dna
|
|
GB0502482D0
(en)
|
2005-02-07 |
2005-03-16 |
Glaxo Group Ltd |
Novel compounds
|
|
WO2007086883A2
(en)
|
2005-02-14 |
2007-08-02 |
Sirna Therapeutics, Inc. |
Cationic lipids and formulated molecular compositions containing them
|
|
WO2006105043A2
(en)
|
2005-03-28 |
2006-10-05 |
Dendritic Nanotechnologies, Inc. |
Janus dendrimers and dendrons
|
|
CA2611944A1
(en)
|
2005-06-15 |
2006-12-28 |
Massachusetts Institute Of Technology |
Amine-containing lipids and uses thereof
|
|
ES2937245T3
(es)
|
2005-08-23 |
2023-03-27 |
Univ Pennsylvania |
ARN que contiene nucleósidos modificados y métodos de uso del mismo
|
|
US9012219B2
(en)
|
2005-08-23 |
2015-04-21 |
The Trustees Of The University Of Pennsylvania |
RNA preparations comprising purified modified RNA for reprogramming cells
|
|
WO2007031091A2
(en)
|
2005-09-15 |
2007-03-22 |
Santaris Pharma A/S |
Rna antagonist compounds for the modulation of p21 ras expression
|
|
EP1948674A4
(en)
|
2005-11-02 |
2009-02-04 |
Protiva Biotherapeutics Inc |
MODIFIED SIRNA MOLECULES AND APPLICATIONS THEREOF
|
|
US7238791B1
(en)
|
2005-12-16 |
2007-07-03 |
Roche Diagnostics Operations, Inc. |
6-monoacetylmorphine derivatives useful in immunoassay
|
|
US20090221684A1
(en)
|
2005-12-22 |
2009-09-03 |
Trustees Of Boston University |
Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof
|
|
CN100569877C
(zh)
|
2005-12-30 |
2009-12-16 |
财团法人工业技术研究院 |
含多uv交联反应基的分枝状结构化合物及其应用
|
|
US20070281336A1
(en)
|
2006-04-14 |
2007-12-06 |
Epicentre Technologies |
Kits and methods for generating 5' capped RNA
|
|
US9085778B2
(en)
|
2006-05-03 |
2015-07-21 |
VL27, Inc. |
Exosome transfer of nucleic acids to cells
|
|
US20070275923A1
(en)
|
2006-05-25 |
2007-11-29 |
Nastech Pharmaceutical Company Inc. |
CATIONIC PEPTIDES FOR siRNA INTRACELLULAR DELIVERY
|
|
US8808681B2
(en)
|
2006-06-05 |
2014-08-19 |
Massachusetts Institute Of Technology |
Crosslinked, degradable polymers and uses thereof
|
|
US20080113357A1
(en)
*
|
2006-06-29 |
2008-05-15 |
Millipore Corporation |
Filter device for the isolation of a nucleic acid
|
|
US20090186805A1
(en)
|
2006-07-06 |
2009-07-23 |
Aaron Thomas Tabor |
Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
|
|
ES2293834B1
(es)
|
2006-07-20 |
2009-02-16 |
Consejo Superior Investig. Cientificas |
Compuesto con actividad inhibidora de las interacciones ubc13-uev, composiciones farmaceuticas que lo comprenden y sus aplicaciones terapeuticas.
|
|
EP2046266A4
(en)
|
2006-07-21 |
2009-11-04 |
Massachusetts Inst Technology |
ENDMODICIFIED POLY (BETA AMINO ESTER) AND ITS USE
|
|
DK2068886T3
(da)
|
2006-10-03 |
2013-11-18 |
Tekmira Pharmaceuticals Corp |
Lipidholdige præparater
|
|
DE102006051516A1
(de)
|
2006-10-31 |
2008-05-08 |
Curevac Gmbh |
(Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins
|
|
DK2104739T3
(da)
|
2006-12-21 |
2013-10-07 |
Novozymes Inc |
Modificerede messenger-RNA-stabiliseringssekvenser til ekspression af gener i bakterieceller
|
|
DE102007001370A1
(de)
|
2007-01-09 |
2008-07-10 |
Curevac Gmbh |
RNA-kodierte Antikörper
|
|
US20100092572A1
(en)
*
|
2007-01-29 |
2010-04-15 |
Peter Kaeuper |
Chitosan-based colloidal particles for rna delivery
|
|
US8859229B2
(en)
|
2007-02-02 |
2014-10-14 |
Yale University |
Transient transfection with RNA
|
|
WO2008113364A2
(en)
|
2007-03-20 |
2008-09-25 |
Recepticon Aps |
Amino derivatives to prevent nephrotoxicity and cancer
|
|
JP5186126B2
(ja)
|
2007-03-29 |
2013-04-17 |
公益財団法人地球環境産業技術研究機構 |
新規トリアジン誘導体ならびにその製法およびそのガス分離膜としての用途
|
|
MX2009011165A
(es)
|
2007-04-18 |
2009-12-09 |
Cornerstone Pharmaceuticals In |
Formulaciones farmaceuticas que contienen derivados del acido lipoico.
|
|
WO2008137470A1
(en)
|
2007-05-01 |
2008-11-13 |
Pgr-Solutions |
Multi-chain lipophilic polyamines
|
|
US20090163705A1
(en)
|
2007-05-21 |
2009-06-25 |
Alnylam Pharmaceuticals, Inc. |
Cationic lipids
|
|
EP2197495A2
(en)
|
2007-10-02 |
2010-06-23 |
MDRNA, Inc. |
Lipopeptides for delivery of nucleic acids
|
|
AU2008333811B2
(en)
|
2007-12-04 |
2014-05-01 |
Alnylam Pharmaceuticals, Inc. |
Carbohydrate conjugates as delivery agents for oligonucleotides
|
|
WO2009120247A2
(en)
|
2007-12-27 |
2009-10-01 |
The Ohio State University Research Foundation |
Lipid nanoparticle compositions and methods of making and using the same
|
|
WO2009082817A1
(en)
|
2007-12-27 |
2009-07-09 |
Protiva Biotherapeutics, Inc. |
Silencing of polo-like kinase expression using interfering rna
|
|
US20110097720A1
(en)
|
2008-01-02 |
2011-04-28 |
Alnylam Pharmaceuticals, Inc. |
Screening method for selected amino lipid-containing compositions
|
|
FR2926560A1
(fr)
*
|
2008-01-21 |
2009-07-24 |
Millipore Corp |
Procede d'extraction et de purification d'acides nucleiques sur membrane
|
|
WO2009100254A2
(en)
*
|
2008-02-05 |
2009-08-13 |
Brent Townshend |
Protein tyrosine phosphatase inhibitors
|
|
EP2274425A2
(en)
|
2008-04-11 |
2011-01-19 |
Alnylam Pharmaceuticals Inc. |
Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
|
|
AU2009238175C1
(en)
|
2008-04-15 |
2023-11-30 |
Arbutus Biopharma Corporation |
Novel lipid formulations for nucleic acid delivery
|
|
US20090263407A1
(en)
|
2008-04-16 |
2009-10-22 |
Abbott Laboratories |
Cationic Lipids and Uses Thereof
|
|
WO2009127230A1
(en)
|
2008-04-16 |
2009-10-22 |
Curevac Gmbh |
MODIFIED (m)RNA FOR SUPPRESSING OR AVOIDING AN IMMUNOSTIMULATORY RESPONSE AND IMMUNOSUPPRESSIVE COMPOSITION
|
|
EP2297322A1
(en)
|
2008-06-04 |
2011-03-23 |
The Board of Regents of The University of Texas System |
Modulation of gene expression through endogenous small rna targeting of gene promoters
|
|
US20100029501A1
(en)
|
2008-07-09 |
2010-02-04 |
Eva Samal |
Method of identifying micro-rna targets
|
|
US20100035249A1
(en)
|
2008-08-05 |
2010-02-11 |
Kabushiki Kaisha Dnaform |
Rna sequencing and analysis using solid support
|
|
JP5492207B2
(ja)
*
|
2008-08-27 |
2014-05-14 |
ライフ テクノロジーズ コーポレーション |
生物学的サンプルの処理装置および処理方法
|
|
JP2010053108A
(ja)
|
2008-08-29 |
2010-03-11 |
Asahi Kasei Corp |
荷電を有する限外濾過膜を用いた生体成分の分離方法およびモジュール、装置
|
|
AU2009303345B2
(en)
|
2008-10-09 |
2015-08-20 |
Arbutus Biopharma Corporation |
Improved amino lipids and methods for the delivery of nucleic acids
|
|
CN104382853A
(zh)
|
2008-10-16 |
2015-03-04 |
玛瑞纳生物技术有限公司 |
基因沉默治疗剂的脂质体有效递送方法和组合物
|
|
US9080211B2
(en)
|
2008-10-24 |
2015-07-14 |
Epicentre Technologies Corporation |
Transposon end compositions and methods for modifying nucleic acids
|
|
WO2010062322A2
(en)
|
2008-10-27 |
2010-06-03 |
Massachusetts Institute Of Technology |
Modulation of the immune response
|
|
JP6087504B2
(ja)
|
2008-11-07 |
2017-03-01 |
マサチューセッツ インスティテュート オブ テクノロジー |
アミノアルコールリピドイドおよびその使用
|
|
HUE037082T2
(hu)
|
2008-11-10 |
2018-08-28 |
Arbutus Biopharma Corp |
Új lipidek és készítmények terápiás hatóanyagok szállítására
|
|
CA2742689A1
(en)
|
2008-11-17 |
2010-05-20 |
Enzon Pharmaceuticals, Inc. |
Branched cationic lipids for nucleic acids delivery system
|
|
EP3156494B8
(en)
*
|
2008-12-04 |
2018-09-19 |
Sangamo Therapeutics, Inc. |
Genome editing in rats using zinc-finger nucleases
|
|
CA2744510A1
(en)
*
|
2008-12-09 |
2010-06-17 |
F.Hoffmann-La Roche Ag |
Method for obtaining an excipient-free antibody solution
|
|
WO2010083615A1
(en)
|
2009-01-26 |
2010-07-29 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing apolipoprotein c-iii expression
|
|
WO2010088517A1
(en)
|
2009-01-30 |
2010-08-05 |
The U.S.A., As Represented By The Secretary, Department Of Health And Human Services |
Methods and systems for purifying transferring and/or manipulating nucleic acids
|
|
US20100222489A1
(en)
|
2009-02-27 |
2010-09-02 |
Jiang Dayue D |
Copolymer composition, membrane article, and methods thereof
|
|
US20100267806A1
(en)
|
2009-03-12 |
2010-10-21 |
David Bumcrot |
LIPID FORMULATED COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Eg5 AND VEGF GENES
|
|
EP2415124B1
(en)
|
2009-04-02 |
2017-02-15 |
The Siemon Company |
Telecommunications patch panel
|
|
JP5713325B2
(ja)
|
2009-04-17 |
2015-05-07 |
アイシス イノヴェイション リミテッド |
遺伝物質の送達用の組成物
|
|
JP5769701B2
(ja)
|
2009-05-05 |
2015-08-26 |
テクミラ ファーマシューティカルズ コーポレイションＴｅｋｍｉｒａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｃｏｒｐｏｒａｔｉｏｎ |
脂質組成物
|
|
DK2440183T3
(en)
|
2009-06-10 |
2018-10-01 |
Arbutus Biopharma Corp |
Improved lipid formulation
|
|
US9051567B2
(en)
|
2009-06-15 |
2015-06-09 |
Tekmira Pharmaceuticals Corporation |
Methods for increasing efficacy of lipid formulated siRNA
|
|
EA201270019A1
(ru)
|
2009-06-15 |
2012-06-29 |
Элнилэм Фармасьютикалз, Инк. |
Двуцепочечная рнк, включенная в липидный состав и мишенью которой является ген pcsk9
|
|
US9018187B2
(en)
|
2009-07-01 |
2015-04-28 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods for the delivery of therapeutic agents
|
|
WO2011000106A1
(en)
|
2009-07-01 |
2011-01-06 |
Protiva Biotherapeutics, Inc. |
Improved cationic lipids and methods for the delivery of therapeutic agents
|
|
EP2449106B1
(en)
|
2009-07-01 |
2015-04-08 |
Protiva Biotherapeutics Inc. |
Compositions and methods for silencing apolipoprotein b
|
|
US8716464B2
(en)
|
2009-07-20 |
2014-05-06 |
Thomas W. Geisbert |
Compositions and methods for silencing Ebola virus gene expression
|
|
MX2012001339A
(es)
|
2009-07-30 |
2012-03-07 |
Salvat Lab Sa |
Compuestos inhibidores de apaf-1.
|
|
EP2459231B1
(de)
|
2009-07-31 |
2016-06-08 |
Ethris Gmbh |
Rna mit einer kombination aus unmodifizierten und modifizierten nucleotiden zur proteinexpression
|
|
WO2011021666A1
(ja)
*
|
2009-08-19 |
2011-02-24 |
国立大学法人奈良先端科学技術大学院大学 |
環境ストレス下の翻訳抑制を回避する5'utrをコードする組換えｄｎａ分子
|
|
DE102009043342A1
(de)
|
2009-09-29 |
2011-03-31 |
Bayer Technology Services Gmbh |
Stoffe für selbstorganisierte Träger zur kontrollierten Freisetzung eines Wirkstoffs
|
|
US8470585B2
(en)
|
2009-10-15 |
2013-06-25 |
Crucell Holland B.V. |
Process for adenovirus purification from high cell density cultures
|
|
US20130224730A1
(en)
*
|
2009-11-18 |
2013-08-29 |
Arizona Board Of Regents Acting For And On Behalf Of Arizona State University |
Peptide ligands
|
|
PL3338765T3
(pl)
|
2009-12-01 |
2019-06-28 |
Translate Bio, Inc. |
Pochodna steroidowa dla dostarczania mrna w ludzkich chorobach genetycznych
|
|
KR102505097B1
(ko)
|
2009-12-07 |
2023-03-02 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
세포 리프로그래밍을 위한 정제된 변형 ｒｎａ를 포함하는 ｒｎａ 제제
|
|
ES2749426T3
(es)
|
2009-12-18 |
2020-03-20 |
Univ British Columbia |
Métodos y composiciones para administración de ácidos nucleicos
|
|
EP2516010A2
(en)
|
2009-12-23 |
2012-10-31 |
Novartis AG |
Lipids, lipid compositions, and methods of using them
|
|
US9315802B2
(en)
*
|
2009-12-30 |
2016-04-19 |
Quest Diagnostics Investments Incorporated |
RNA isolation from soluble urine fractions
|
|
JP2012246222A
(ja)
*
|
2010-01-29 |
2012-12-13 |
Axis Inc |
変形性関節症治療剤または予防剤を製造するための使用
|
|
JP2013527856A
(ja)
|
2010-05-12 |
2013-07-04 |
プロチバ バイオセラピューティクス インコーポレイティッド |
陽イオン性脂質およびその使用方法
|
|
NZ605079A
(en)
|
2010-06-03 |
2015-08-28 |
Alnylam Pharmaceuticals Inc |
Biodegradable lipids for the delivery of active agents
|
|
CN101863544B
(zh)
|
2010-06-29 |
2011-09-28 |
湖南科技大学 |
一种氰尿酸基重金属螯合絮凝剂及其制备方法
|
|
WO2012000104A1
(en)
|
2010-06-30 |
2012-01-05 |
Protiva Biotherapeutics, Inc. |
Non-liposomal systems for nucleic acid delivery
|
|
WO2012016184A2
(en)
|
2010-07-30 |
2012-02-02 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
|
EP3578205A1
(en)
|
2010-08-06 |
2019-12-11 |
ModernaTX, Inc. |
A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof
|
|
WO2012019630A1
(en)
|
2010-08-13 |
2012-02-16 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded protein
|
|
DK2607482T3
(en)
|
2010-08-18 |
2017-07-03 |
Toray Industries |
Solution for extraction of RNA
|
|
JP5740754B2
(ja)
*
|
2010-08-26 |
2015-07-01 |
アイシン精機株式会社 |
酵素結晶固定化電極及び酵素結晶固定化電極の製造方法、並びに酵素結晶固定化電極を備えるバイオ電池及びバイオセンサー
|
|
EP2609135A4
(en)
|
2010-08-26 |
2015-05-20 |
Massachusetts Inst Technology |
POLY (BETA-AMINO ALCOHOLS), THEIR PREPARATION AND USES THEREOF
|
|
WO2012031294A2
(en)
*
|
2010-09-03 |
2012-03-08 |
University Of Maryland, College Park |
Methods for determining protein ligand binding
|
|
US20120237975A1
(en)
|
2010-10-01 |
2012-09-20 |
Jason Schrum |
Engineered nucleic acids and methods of use thereof
|
|
WO2012075040A2
(en)
|
2010-11-30 |
2012-06-07 |
Shire Human Genetic Therapies, Inc. |
mRNA FOR USE IN TREATMENT OF HUMAN GENETIC DISEASES
|
|
KR20140092227A
(ko)
*
|
2010-12-10 |
2014-07-23 |
트레이시 톰슨 |
분리 방법용 조성물
|
|
PL2691443T3
(pl)
|
2011-03-28 |
2021-08-30 |
Massachusetts Institute Of Technology |
Sprzężone lipomery i ich zastosowania
|
|
EP2691101A2
(en)
|
2011-03-31 |
2014-02-05 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
|
WO2012133737A1
(ja)
|
2011-03-31 |
2012-10-04 |
公益財団法人地球環境産業技術研究機構 |
架橋性アミン化合物、該化合物を用いた高分子膜及びその製造方法
|
|
US11767534B2
(en)
|
2011-05-04 |
2023-09-26 |
The Broad Institute, Inc. |
Multiplexed genetic reporter assays and compositions
|
|
CA2835428A1
(en)
|
2011-05-17 |
2012-11-22 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof for non-human vertebrates
|
|
EP2532649B1
(en)
|
2011-06-07 |
2015-04-08 |
Incella GmbH |
Amino lipids, their synthesis and uses thereof
|
|
CN103748078B
(zh)
|
2011-06-08 |
2016-11-09 |
夏尔人类遗传性治疗公司 |
可裂解脂质
|
|
EP4043025A1
(en)
|
2011-06-08 |
2022-08-17 |
Translate Bio, Inc. |
Lipid nanoparticle compositions and methods for mrna delivery
|
|
WO2013003475A1
(en)
|
2011-06-27 |
2013-01-03 |
Cellscript, Inc. |
Inhibition of innate immune response
|
|
KR20140045398A
(ko)
|
2011-06-30 |
2014-04-16 |
시그마-알드리치 컴퍼니., 엘엘씨 |
Cmp-n-아세틸뉴라민산 하이드록실라제 및/또는 당단백질 알파-1,3-갈락토실트랜스퍼라제가 결핍된 세포
|
|
WO2013039861A2
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
|
WO2013039857A1
(en)
|
2011-09-12 |
2013-03-21 |
modeRNA Therapeutics |
Engineered nucleic acids and methods of use thereof
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
RU2014117690A
(ru)
|
2011-10-05 |
2015-11-10 |
Протива Байотерапьютикс Инк. |
Композиции и способы для сайленсинга альдегид-дегидрогеназы
|
|
AU2012328570B2
(en)
|
2011-10-27 |
2017-08-31 |
Massachusetts Institute Of Technology |
Amino acid derivatives functionalized on the n-terminus capable of forming drug encapsulating microspheres and uses thereof
|
|
US20140343129A1
(en)
|
2011-12-14 |
2014-11-20 |
Moderna Therapeutics, Inc. |
Modified nucleic acids, and acute care uses thereof
|
|
US20140378538A1
(en)
|
2011-12-14 |
2014-12-25 |
Moderma Therapeutics, Inc. |
Methods of responding to a biothreat
|
|
WO2013090814A2
(en)
*
|
2011-12-16 |
2013-06-20 |
Board Of Trustees Of Michigan State University |
p-Coumaroyl-CoA:Monolignol Transferase
|
|
KR20140102759A
(ko)
|
2011-12-16 |
2014-08-22 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
|
|
AU2012358384A1
(en)
|
2011-12-21 |
2014-07-31 |
Moderna Therapeutics, Inc. |
Methods of increasing the viability or longevity of an organ or organ explant
|
|
US20140371302A1
(en)
|
2011-12-29 |
2014-12-18 |
Modema Therapeutics, Inc. |
Modified mrnas encoding cell-penetrating polypeptides
|
|
PL3421601T3
(pl)
|
2011-12-30 |
2020-06-01 |
Cellscript, Llc |
Wytwarzanie i stosowanie zsyntetyzowanego in vitro ssRNA do wprowadzania do ssaczych komórek w celu indukcji efektu biologicznego lub biochemicznego
|
|
US9352042B2
(en)
|
2012-02-24 |
2016-05-31 |
Protiva Biotherapeutics, Inc. |
Trialkyl cationic lipids and methods of use thereof
|
|
CN104334161A
(zh)
|
2012-03-29 |
2015-02-04 |
夏尔人类遗传性治疗公司 |
可电离的阳离子脂质
|
|
CN104487055A
(zh)
|
2012-03-29 |
2015-04-01 |
夏尔人类遗传性治疗公司 |
脂质衍生的中性纳米颗粒
|
|
US20150050354A1
(en)
|
2012-04-02 |
2015-02-19 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the treatment of otic diseases and conditions
|
|
US9878056B2
(en)
|
2012-04-02 |
2018-01-30 |
Modernatx, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
AU2013243949A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of biologics and proteins associated with human disease
|
|
US20140275229A1
(en)
|
2012-04-02 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Modified polynucleotides encoding udp glucuronosyltransferase 1 family, polypeptide a1
|
|
CA2868398A1
(en)
|
2012-04-02 |
2013-10-10 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cosmetic proteins and peptides
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
EP3884949A1
(en)
|
2012-06-08 |
2021-09-29 |
Translate Bio, Inc. |
Pulmonary delivery of mrna to non-lung target cells
|
|
CA2873274C
(en)
*
|
2012-06-08 |
2021-06-01 |
Ethris Gmbh |
Pulmonary delivery of messenger rna
|
|
EP2859102A4
(en)
|
2012-06-08 |
2016-05-11 |
Shire Human Genetic Therapies |
NUCLEASE RESISTANT POLYNUCLEOTIDES AND USES THEREOF
|
|
EP2674167A1
(en)
*
|
2012-06-14 |
2013-12-18 |
PLS-Design GmbH |
Controlled activation of complement components for use as endogenous adjuvant
|
|
WO2014028487A1
(en)
|
2012-08-13 |
2014-02-20 |
Massachusetts Institute Of Technology |
Amine-containing lipidoids and uses thereof
|
|
CN104995311A
(zh)
|
2012-08-30 |
2015-10-21 |
外来体诊断公司 |
用于核酸测定的对照
|
|
US20140093952A1
(en)
*
|
2012-10-02 |
2014-04-03 |
David Serway |
Bioreactor Tangential Flow Perfusion Filter System
|
|
US20150307542A1
(en)
|
2012-10-03 |
2015-10-29 |
Moderna Therapeutics, Inc. |
Modified nucleic acid molecules and uses thereof
|
|
CA2892035C
(en)
|
2012-11-21 |
2019-11-05 |
Serum Institute Of India Ltd. |
Production of neisseria meningitidis x capsular polysaccharide
|
|
JP6144355B2
(ja)
|
2012-11-26 |
2017-06-07 |
モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． |
化学修飾ｍＲＮＡ
|
|
WO2014089486A1
(en)
|
2012-12-07 |
2014-06-12 |
Shire Human Genetic Therapies, Inc. |
Lipidic nanoparticles for mrna delivering
|
|
WO2014093574A1
(en)
|
2012-12-13 |
2014-06-19 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for altering cell phenotype
|
|
CA2897941A1
(en)
|
2013-01-17 |
2014-07-24 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
WO2014158795A1
(en)
|
2013-03-12 |
2014-10-02 |
Moderna Therapeutics, Inc. |
Diagnosis and treatment of fibrosis
|
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
|
ES2680595T3
(es)
|
2013-03-14 |
2018-09-10 |
Translate Bio, Inc. |
Evaluación cuantitativa para eficacia de ARN mensajero para tapar
|
|
KR20150127582A
(ko)
|
2013-03-14 |
2015-11-17 |
샤이어 휴먼 지네틱 테라피즈 인크. |
4''-티오 개질된 뉴클레오티드를 갖는 리보핵산 및 관련 방법
|
|
ES2708562T3
(es)
|
2013-03-14 |
2019-04-10 |
Translate Bio Inc |
Evaluación cuantitativa de la eficacidad de tapa de ARN mensajero
|
|
HUE055044T2
(hu)
|
2013-03-14 |
2021-10-28 |
Translate Bio Inc |
MRNS-kódolt ellenanyagok bejuttatására szolgáló eljárások és készítmények
|
|
PT2968586T
(pt)
|
2013-03-14 |
2018-11-13 |
Ethris Gmbh |
Composições de arnm de cftr e métodos e utilizações relacionados
|
|
US10258698B2
(en)
|
2013-03-14 |
2019-04-16 |
Modernatx, Inc. |
Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
|
|
EP2970955B1
(en)
|
2013-03-14 |
2018-11-14 |
Translate Bio, Inc. |
Methods for purification of messenger rna
|
|
WO2014152940A1
(en)
|
2013-03-14 |
2014-09-25 |
Shire Human Genetic Therapies, Inc. |
Mrna therapeutic compositions and use to treat diseases and disorders
|
|
WO2014144711A1
(en)
|
2013-03-15 |
2014-09-18 |
Moderna Therapeutics, Inc. |
Analysis of mrna heterogeneity and stability
|
|
US20160032273A1
(en)
|
2013-03-15 |
2016-02-04 |
Moderna Therapeutics, Inc. |
Characterization of mrna molecules
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
ES2923018T3
(es)
|
2013-03-15 |
2022-09-22 |
Glaxosmithkline Biologicals Sa |
Métodos de purificación de ARN
|
|
US10077439B2
(en)
|
2013-03-15 |
2018-09-18 |
Modernatx, Inc. |
Removal of DNA fragments in mRNA production process
|
|
US11377470B2
(en)
|
2013-03-15 |
2022-07-05 |
Modernatx, Inc. |
Ribonucleic acid purification
|
|
EP2983804A4
(en)
|
2013-03-15 |
2017-03-01 |
Moderna Therapeutics, Inc. |
Ion exchange purification of mrna
|
|
EP3388834B1
(en)
|
2013-03-15 |
2020-04-15 |
Translate Bio, Inc. |
Synergistic enhancement of the delivery of nucleic acids via blended formulations
|
|
US10138507B2
(en)
*
|
2013-03-15 |
2018-11-27 |
Modernatx, Inc. |
Manufacturing methods for production of RNA transcripts
|
|
US9315472B2
(en)
|
2013-05-01 |
2016-04-19 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
|
US9895443B2
(en)
|
2013-06-26 |
2018-02-20 |
Massachusetts Institute Of Technology |
Multi-tailed lipids and uses thereof
|
|
DK3019619T3
(da)
|
2013-07-11 |
2021-10-11 |
Modernatx Inc |
Sammensætninger, der omfatter syntetiske polynukleotider, som koder for crispr-beslægtede proteiner, og syntetiske sgrna'er, og anvendelsesfremgangsmåder
|
|
JP6620093B2
(ja)
|
2013-07-23 |
2019-12-11 |
アービュートゥス バイオファーマ コーポレイションＡｒｂｕｔｕｓ Ｂｉｏｐｈａｒｍａ Ｃｏｒｐｏｒａｔｉｏｎ |
メッセンジャーｒｎａを送達するための組成物及び方法
|
|
US20160194368A1
(en)
|
2013-09-03 |
2016-07-07 |
Moderna Therapeutics, Inc. |
Circular polynucleotides
|
|
WO2015034928A1
(en)
|
2013-09-03 |
2015-03-12 |
Moderna Therapeutics, Inc. |
Chimeric polynucleotides
|
|
EP3052106A4
(en)
|
2013-09-30 |
2017-07-19 |
ModernaTX, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
WO2015051173A2
(en)
|
2013-10-02 |
2015-04-09 |
Moderna Therapeutics, Inc |
Polynucleotide molecules and uses thereof
|
|
US10385088B2
(en)
|
2013-10-02 |
2019-08-20 |
Modernatx, Inc. |
Polynucleotide molecules and uses thereof
|
|
EP3058082A4
(en)
|
2013-10-18 |
2017-04-26 |
ModernaTX, Inc. |
Compositions and methods for tolerizing cellular systems
|
|
AU2014340092B2
(en)
|
2013-10-22 |
2019-09-19 |
Translate Bio, Inc. |
mRNA therapy for Argininosuccinate Synthetase Deficiency
|
|
WO2015061491A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Mrna therapy for phenylketonuria
|
|
WO2015061461A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Cns delivery of mrna and uses thereof
|
|
US20170173128A1
(en)
|
2013-12-06 |
2017-06-22 |
Moderna TX, Inc. |
Targeted adaptive vaccines
|
|
EP2918275B1
(en)
|
2013-12-13 |
2016-05-18 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules and uses thereof
|
|
EP3083579B1
(en)
*
|
2013-12-19 |
2022-01-26 |
Novartis AG |
Lipids and lipid compositions for the delivery of active agents
|
|
US20170002060A1
(en)
|
2014-01-08 |
2017-01-05 |
Moderna Therapeutics, Inc. |
Polynucleotides for the in vivo production of antibodies
|
|
CA2946751A1
(en)
|
2014-04-23 |
2015-10-29 |
Modernatx, Inc. |
Nucleic acid vaccines
|
|
SG11201608725YA
(en)
|
2014-04-25 |
2016-11-29 |
Shire Human Genetic Therapies |
Methods for purification of messenger rna
|
|
JP2017536092A
(ja)
|
2014-10-02 |
2017-12-07 |
プロティバ バイオセラピューティクス インコーポレイテッド |
Ｂ型肝炎ウイルスの遺伝子発現をサイレンシングするための組成物及び方法
|
|
WO2016071857A1
(en)
|
2014-11-07 |
2016-05-12 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing ebola virus expression
|
|
EP3461904A1
(en)
|
2014-11-10 |
2019-04-03 |
ModernaTX, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
|
EP3218508A4
(en)
|
2014-11-10 |
2018-04-18 |
Modernatx, Inc. |
Multiparametric nucleic acid optimization
|
|
US20180000953A1
(en)
|
2015-01-21 |
2018-01-04 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
|
EP3247398A4
(en)
|
2015-01-23 |
2018-09-26 |
Moderna Therapeutics, Inc. |
Lipid nanoparticle compositions
|
|
US20180245077A1
(en)
|
2015-03-20 |
2018-08-30 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for treating hypertriglyceridemia
|
|
WO2016164762A1
(en)
|
2015-04-08 |
2016-10-13 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor egf-a and intracellular domain mutants and methods of using the same
|
|
WO2016183366A2
(en)
|
2015-05-12 |
2016-11-17 |
Protiva Biotherapeutics, Inc. |
Compositions and methods for silencing expression of hepatitis d virus rna
|
|
EP3744843A1
(en)
|
2015-05-29 |
2020-12-02 |
CureVac Real Estate GmbH |
A method for producing and purifying rna, comprising at least one step of tangential flow filtration
|
|
US20180245074A1
(en)
|
2015-06-04 |
2018-08-30 |
Protiva Biotherapeutics, Inc. |
Treating hepatitis b virus infection using crispr
|
|
US10626393B2
(en)
|
2015-06-04 |
2020-04-21 |
Arbutus Biopharma Corporation |
Delivering CRISPR therapeutics with lipid nanoparticles
|
|
WO2016201377A1
(en)
|
2015-06-10 |
2016-12-15 |
Moderna Therapeutics, Inc. |
Targeted adaptive vaccines
|
|
US11920174B2
(en)
|
2016-03-03 |
2024-03-05 |
CureVac SE |
RNA analysis by total hydrolysis and quantification of released nucleosides
|